Xilio Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
02 Apr 24 | BuyUS$368,790 | Gilead Sciences, Inc. | Company | 485,250 | US$0.76 | |
08 Feb 24 | SellUS$640 | Atlas Venture L.P. | Company | 1,000 | US$0.64 | |
12 Jan 24 | SellUS$3,600 | Atlas Venture L.P. | Company | 4,235 | US$0.87 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 13,975 | 0.0405% |
Individual Insiders | 206,635 | 0.6% |
Hedge Funds | 3,003,259 | 8.71% |
Public Companies | 7,345,473 | 21.3% |
VC/PE Firms | 7,467,193 | 21.7% |
General Public | 7,589,521 | 22% |
Institutions | 8,841,813 | 25.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,345,473 | US$8.1m | 0% | no data | |||
3,003,259 | US$3.3m | 108% | 0.1% | |||
2,805,413 | US$3.1m | 0% | 0.32% | |||
2,754,109 | US$3.0m | -0.19% | 0.34% | |||
1,907,671 | US$2.1m | 0% | 0.91% | |||
1,613,632 | US$1.8m | 0% | 100.0% | |||
1,483,414 | US$1.6m | 0% | 7.47% | |||
1,475,121 | US$1.6m | 0% | 36.14% | |||
1,441,444 | US$1.6m | 0% | 20.25% | |||
902,531 | US$992.8k | 1.37% | no data | |||
450,000 | US$495.0k | 0% | 0.02% | |||
249,635 | US$274.6k | 0% | 0.56% | |||
218,705 | US$240.6k | 0% | no data | |||
209,700 | US$230.7k | 913% | no data | |||
200,633 | US$220.7k | 0% | no data | |||
155,481 | US$171.0k | 40.7% | no data | |||
127,265 | US$140.0k | 385% | no data | |||
116,847 | US$128.5k | -16.1% | no data | |||
84,826 | US$93.3k | 0% | no data | |||
83,373 | US$91.7k | 0% | no data | |||
51,419 | US$56.6k | 0% | no data | |||
46,862 | US$51.5k | -1.1% | no data | |||
30,351 | US$33.4k | 0% | no data | |||
26,449 | US$29.1k | 0% | no data | |||
17,798 | US$19.6k | 0% | no data |